An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.
Al-Samkari H, Kasthuri RS, Parambil JG, Albitar HA, Almodallal YA, Vázquez C, Serra MM, Dupuis-Girod S, Wilsen CB, McWilliams JP, Fountain EH, Gossage JR, Weiss CR, Latif MA, Issachar A, Mei-Zahav M, Meek ME, Conrad M, Rodriguez-Lopez J, Kuter DJ, Iyer VN.
Al-Samkari H, et al. Among authors: latif ma.
Haematologica. 2021 Aug 1;106(8):2161-2169. doi: 10.3324/haematol.2020.261859.
Haematologica. 2021.
PMID: 32675221
Free PMC article.